Amalgamated Bank Sells 3,371 Shares of Amedisys, Inc. (NASDAQ:AMED)

Amalgamated Bank trimmed its position in Amedisys, Inc. (NASDAQ:AMED) by 18.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,149 shares of the health services provider’s stock after selling 3,371 shares during the period. Amalgamated Bank’s holdings in Amedisys were worth $1,462,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in AMED. SG Americas Securities LLC boosted its stake in Amedisys by 41.6% during the 2nd quarter. SG Americas Securities LLC now owns 38,315 shares of the health services provider’s stock valued at $3,517,000 after purchasing an additional 11,264 shares during the last quarter. BNP Paribas Financial Markets boosted its stake in Amedisys by 111.7% during the 1st quarter. BNP Paribas Financial Markets now owns 12,050 shares of the health services provider’s stock valued at $1,111,000 after purchasing an additional 6,358 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Amedisys by 4.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock valued at $47,202,000 after purchasing an additional 19,660 shares during the last quarter. California State Teachers Retirement System boosted its stake in Amedisys by 65.8% during the 1st quarter. California State Teachers Retirement System now owns 54,592 shares of the health services provider’s stock valued at $5,031,000 after purchasing an additional 21,671 shares during the last quarter. Finally, Cetera Advisors LLC acquired a new position in Amedisys during the 1st quarter valued at about $1,556,000. 94.36% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Cantor Fitzgerald restated a “neutral” rating and issued a $101.00 target price on shares of Amedisys in a research note on Thursday, July 25th. Deutsche Bank Aktiengesellschaft downgraded Amedisys from a “buy” rating to a “hold” rating and set a $101.00 target price on the stock. in a research note on Monday, July 29th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $100.67.

Amedisys Trading Down 1.8 %

Amedisys stock opened at $91.00 on Wednesday. The stock has a market cap of $2.98 billion, a P/E ratio of 36.11, a PEG ratio of 1.90 and a beta of 0.78. Amedisys, Inc. has a fifty-two week low of $89.55 and a fifty-two week high of $98.95. The firm’s fifty day moving average price is $96.46 and its 200-day moving average price is $95.89. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.16 and a current ratio of 1.19.

Amedisys (NASDAQ:AMED) last released its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). The firm had revenue of $587.67 million during the quarter, compared to the consensus estimate of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The company’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.98 EPS. Equities research analysts forecast that Amedisys, Inc. will post 4.62 earnings per share for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.